Page last updated: 2024-10-29

irsogladine and Stomatitis, Aphthous

irsogladine has been researched along with Stomatitis, Aphthous in 5 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Stomatitis, Aphthous: A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742)

Research Excerpts

ExcerptRelevanceReference
"Irsogladine 2-4 mg/day was administered orally to ten BD patients (cases 1-10), three men and seven women, with a mean age of 48."2.73Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study. ( Kamatani, N; Kotake, S; Nanke, Y; Ogiuchi, H; Okamoto, T, 2008)
"Aphthous stomatitis is one of the adverse effects associated with interferon (IFN) that forces dose reduction of IFN and there is no established therapy."1.39Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study. ( Arisawa, T; George, J; Hayashi, N; Saito, T; Shiroeda, H; Toshikuni, N; Tsuchishima, M; Tsutsumi, M, 2013)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, N1
George, J1
Shiroeda, H1
Saito, T1
Toshikuni, N1
Tsuchishima, M1
Arisawa, T1
Tsutsumi, M1
Nanke, Y1
Kamatani, N1
Okamoto, T1
Ogiuchi, H1
Kotake, S1
Yoshida, T1
Hirakata, M1
Hara, A2
Murata, T1
Uemura, R1
Miura, T1
Fukui, K1
Matsukawa, H1
Kasiwagi, K1
Ito, T2
Yoshioka, M2
Hibi, T2
Nishizawa, M1
Ichikawa, M1
Takahashi, S1
Hiida, M1
Takemori, M1
Ishihara, N1

Trials

1 trial available for irsogladine and Stomatitis, Aphthous

ArticleYear
Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
    Drugs in R&D, 2008, Volume: 9, Issue:6

    Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Behcet Syndrome; Cell Communication; Female; Follow-

2008

Other Studies

4 other studies available for irsogladine and Stomatitis, Aphthous

ArticleYear
Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study.
    Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:6

    Topics: Anti-Ulcer Agents; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Inter

2013
Therapeutic benefits of irsogladine maleate on aphthous stomatitis induced by methotrexate in rheumatoid arthritis.
    The Journal of rheumatology, 2003, Volume: 30, Issue:9

    Topics: Aged; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female;

2003
Identification of connexins in human oral mucosa and therapeutic effect of irsogladine maleate on aphthous stomatitis.
    Journal of gastroenterology, 1999, Volume: 34, Issue:1

    Topics: Adult; Aged; Anti-Ulcer Agents; Cell Communication; Connexins; Female; Fluorescent Antibody Techniqu

1999
[A case of idiopathic relapsing aphthous stomatitis which was effectively treated by irsogladine maleate].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2001, Volume: 98, Issue:12

    Topics: Administration, Oral; Aged; Female; Humans; Recurrence; Stomatitis, Aphthous; Triazines

2001